2022
DOI: 10.3389/fmed.2021.812278
|View full text |Cite
|
Sign up to set email alerts
|

Over-Expression and Prognostic Significance of FN1, Correlating With Immune Infiltrates in Thyroid Cancer

Abstract: BackgroundThyroid cancer (THCA) is a malignancy affecting the endocrine system, which currently has no effective treatment due to a limited number of suitable drugs and prognostic markers.MethodsThree Gene Expression Omnibus (GEO) datasets were selected to identify differentially expressed genes (DEGs) between THCA and normal thyroid samples using GEO2R tools of National Center for Biotechnology Information. We identified hub gene FN1 using functional enrichment and protein-protein interaction network analyses… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 39 publications
1
18
0
Order By: Relevance
“…In thyroid cancer, overexpression of FN1 is found to be strongly correlated with the infiltration levels of M2 macrophages. 56 Similar results were also acquired from a study in Switzerland, showing that FN1 was linked to the M2 TAM phenotype in renal carcinoma, associated with poor survival and increased tumor stage. 57 Consistently, Yoshida et al 58 revealed that cellular FN1 promoted the secretion level of M2 marker (interleukin-10, IL-10) and reduced M1 marker (tumor necrosis factor-alpha, TNF-α) in macrophages in a concentration-dependent manner.…”
Section: Discussionsupporting
confidence: 72%
“…In thyroid cancer, overexpression of FN1 is found to be strongly correlated with the infiltration levels of M2 macrophages. 56 Similar results were also acquired from a study in Switzerland, showing that FN1 was linked to the M2 TAM phenotype in renal carcinoma, associated with poor survival and increased tumor stage. 57 Consistently, Yoshida et al 58 revealed that cellular FN1 promoted the secretion level of M2 marker (interleukin-10, IL-10) and reduced M1 marker (tumor necrosis factor-alpha, TNF-α) in macrophages in a concentration-dependent manner.…”
Section: Discussionsupporting
confidence: 72%
“…On the other hand, the disruptions of the structure or function of fibronectin can lead to remarkable changes in ECM organization and result in a number of disorders in organisms, including cancer [ 23 ]. The increased expression of FN1 gene has been reported in many types of cancer, including gastric [ 24 ], breast [ 25 ], thyroid [ 26 ], renal [ 27 ] and ovarian [ 28 ] cancers. Furthermore, in many cases, the up-regulation of FN1 indicates a poor prognosis for patients [ 24 , 26 , 28 ].…”
Section: Discussionmentioning
confidence: 99%
“…The increased expression of FN1 gene has been reported in many types of cancer, including gastric [ 24 ], breast [ 25 ], thyroid [ 26 ], renal [ 27 ] and ovarian [ 28 ] cancers. Furthermore, in many cases, the up-regulation of FN1 indicates a poor prognosis for patients [ 24 , 26 , 28 ]. The elevated expression level of fibronectin 1 is strongly related to modifications of extracellular space, and it contributes and promotes the spread, migration, proliferation and differentiation of cells [ 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…CD276, an immune checkpoint from the B7 superfamily, is highly expressed in TAMs and functionally suppressed DCs of TME. It can inhibit proliferation and activation of CTL, thus closely affecting tumor progression and metastasis (Geng, Huang et al 2022). Therefore, our study suggested that ALKBH1 might improve the prognosis of PAAD patients by downregulating CD276 expression.…”
Section: Discussionmentioning
confidence: 99%